Long-Term Liabilities: The sum of all non-current liabilities.
Alamar Biosciences, Inc. (ALMR) had Long-Term Liabilities of $50.16M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$29.43M |
|
$-13.20M |
|
$11.71M |
|
$17.72M |
|
$42.96M |
|
$-13.53M |
|
$0.24M |
|
$-13.29M |
|
$-13.29M |
|
$-13.20M |
|
$-13.20M |
|
$-13.20M |
|
$-13.20M |
|
$-13.53M |
|
$-12.46M |
|
58.67M |
|
58.67M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$331.38M |
|
$13.36M |
|
$59.59M |
|
$390.98M |
|
$27.96M |
|
$9.95M |
|
|
Long-Term Liabilities |
$50.16M |
$78.12M |
|
$312.86M |
|
$311.25M |
|
$312.86M |
|
69.39M |
|
| Cash Flow Statement Financials | |
$-31.67M |
|
$-121.57M |
|
$257.60M |
|
$34.91M |
|
$139.22M |
|
$104.31M |
|
$4.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.85 |
|
-- |
|
-- |
|
0.03 |
|
0.03 |
|
60.21% |
|
-45.98% |
|
-45.98% |
|
-- |
|
-45.17% |
|
-44.85% |
|
$-35.91M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.26 |
|
1.45 |
|
62.22 |
|
-4.22% |
|
-4.24% |
|
-3.38% |
|
-4.09% |
|
$4.51 |
|
$-0.61 |
|
$-0.54 |
|